ImmuneSensor Therapeutics Inc.
5 clinical trials · Sponsor
◉ Watch ImmuneSensor Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1b Safety Study of IMSB301 in Type 1 Interferonopathies (NCT07364513) | ImmuneSensor Therapeutics Inc. | 2026-01-12 |
| A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial (NCT06026254) | ImmuneSensor Therapeutics Inc. | 2023-09-15 |
| Study of PULSAR-ICI +/- IMSA101 in Patients With Oligoprogressive Solid Tumor Malignancies (NCT05846659) | ImmuneSensor Therapeutics Inc. | 2023-07-07 |
| Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC (NCT05846646) | ImmuneSensor Therapeutics Inc. | 2023-06-28 |
| Safety and Efficacy Study of IMSA101 in Refractory Malignancies (NCT04020185) | ImmuneSensor Therapeutics Inc. | 2019-09-23 |
Track ImmuneSensor Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.